Bright Minds Biosciences (DRUG) Stock Forecast & Price Target

$39.75 +0.93 (+2.40%)

(As of 12/17/2024 ET)

Bright Minds Biosciences - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Buy

Based on 2 Analyst Ratings

Sell
0

Hold
0

Buy
2

Based on 2 Wall Street analysts who have issued ratings for Bright Minds Biosciences in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 1 has given a buy rating, and 1 has given a strong buy rating for DRUG.

Consensus Price Target

$75.00
88.68% Upside

According to the 2 analysts' twelve-month price targets for Bright Minds Biosciences, the average price target is $75.00. The highest price target for DRUG is $75.00, while the lowest price target for DRUG is $75.00. The average price target represents a forecasted upside of 88.68% from the current price of $39.75.

Get the Latest News and Ratings for DRUG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Bright Minds Biosciences and its competitors.

DRUG Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	1 Strong Buy rating(s)	N/A	N/A	N/A
Buy	1 Buy rating(s)	N/A	N/A	N/A
Hold	0 Hold rating(s)	N/A	N/A	N/A
Sell	0 Sell rating(s)	N/A	N/A	N/A
Consensus Price Target	$75.00	N/A	N/A	N/A
Forecasted Upside	88.68% Upside	N/A	N/A	N/A
Consensus Rating	Strong Buy	N/A	N/A	N/A

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

DRUG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DRUG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bright Minds Biosciences Stock vs. The Competition

Type	Bright Minds Biosciences	Medical Companies	S&P 500
Consensus Rating Score	3.50	2.81	2.51
Consensus Rating	Strong Buy	Moderate Buy	Moderate Buy
Predicted Upside	88.68% Upside	28,675.54% Upside	12.02% Upside
News Sentiment Rating	Positive News See Recent DRUG News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
11/25/2024	Baird R W 0 of 5 stars	J. Beatty Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
11/25/2024	Robert W. Baird 2 of 5 stars		Initiated Coverage	Outperform	$75.00	+94.81%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:39 AM ET.

DRUG Forecast - Frequently Asked Questions

: According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Bright Minds Biosciences is $75.00, with a high forecast of $75.00 and a low forecast of $75.00.
: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bright Minds Biosciences in the last year. There is currently 1 buy rating and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "strong buy" DRUG shares.
: According to analysts, Bright Minds Biosciences's stock has a predicted upside of 88.68% based on their 12-month stock forecasts.
: Over the previous 90 days, Bright Minds Biosciences's stock had 1 upgrade by analysts.
: Bright Minds Biosciences has been rated by research analysts at Baird R W, and Robert W. Baird in the past 90 days.
: Analysts like Bright Minds Biosciences more than other "medical" companies. The consensus rating for Bright Minds Biosciences is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how DRUG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Do this Before Elon’s Reveal on January 22nd (Ad)

Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.

I urge you to watch this video now.

This page (NASDAQ:DRUG) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bright Minds Biosciences (DRUG) Stock Forecast & Price Target